论文部分内容阅读
双特异性抗体或将嵌合的免疫球蛋白/T细胞受体基因转导至T细胞上以导向细胞毒细胞的杀瘤作用已成为肿瘤生物治疗的又一新发展.这种新型的肿瘤生物治疗将单克隆抗体的高度特异性和细胞毒细胞的强大杀伤效应相互结合起来,使细胞毒细胞具有很高的特异性强大杀伤效应,为解决目前过继免疫治疗中的某些缺点开辟了新的道路,有应用前景.
Bispecific antibodies or the killing effect of transducing chimeric immunoglobulin / T cell receptor genes on T cells for targeting cytotoxic cells have become a new development of tumor biological therapy. This novel tumor organism The combination of the high specificity of monoclonal antibodies and the powerful killing effect of cytotoxic cells makes the cytotoxic cells have a highly specific and specific killing effect and has opened a new dimension to solve some shortcomings in current adoptive immunotherapy Road, there are prospects.